Neuro-Ox 2018: Assessment of Cerebral Oxygenation Under Three Clinically Relevant Conditions
1 other identifier
interventional
18
1 country
1
Brief Summary
This is a prospective observational study, consisting of 3 substudies carried out during elective neurosurgery under general anaesthesia. Each participant will take part in all 3 substudies. First, the capability of Near Infra Red Spectroscopy (NIRS) to measure the brain oxygenation is examined. A NIRS-electrode is placed on forehead skin, on the skull, and on dura. Secondly, a small dose of Phenylephrine is given, and the brain oxygenation is measured by a Clark-electrode and a NIRS-electrode, to see how Phenylephrine affects these measurements. In the third substudy, the brain oxygenations' (NIRS and Licox) response to an inspired oxygen fraction of 0.30 vs. 0.80 is investigated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2018
CompletedFirst Posted
Study publicly available on registry
September 24, 2018
CompletedStudy Start
First participant enrolled
September 24, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2020
CompletedNovember 3, 2020
November 1, 2020
2 years
August 28, 2018
November 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
ScO2 (NIRS-measured cerebral oxygen saturation)
Difference in ScO2 between dura and skin (Primary analysis for substudy 1)
During surgical procedure
Secondary Outcomes (4)
PBrO2 (Partial pressure of brain tissue oxygen)
During surgical procedure
PBrO2 (Partial pressure of brain tissue oxygen)
'Normoxia' is induced with FiO2 = 0.30 for 5 minutes, and then changed to 'Hyperoxia' with FiO2 = 0.80 for the subsequent 5 minutes, while registering the Licox-signal.
ScO2 (NIRS-measured cerebral oxygen saturation)
Measurements will be performed as the surgeon exposes the skull.
ScO2 (NIRS-measured cerebral oxygenation)
NIRS signal is obtained continuously during the Phenylephrine intervention
Study Arms (1)
One strategy for all enrolled patients:
OTHERAll patients will participate in three substudies, in which they also act as controls, with exposure to the same three interventions: 1) NIRS-measurement on skin, skull and dura, 2) Phenylephrine 0.1 mg iv., and 3) inspired oxygen fraction of 0.3 vs. 0.8
Interventions
During a neurosurgical procedure, we will measure the brain oxygenation with a NIRS-electrode, first on forehead skin, then on the skull and finally directly on dura.
With a Clark-electrode (Licox(R)) in the white matter and a NIRS-electrode on the forehead skin, we will give a small dose (0.1 mg iv.) Phenylephrine.
By the end of the neurosurgical procedure, still with a Clark-electrode in the white matter and a NIRS-electrode on forehead skin, we will change the inspired oxygen fraction from 0.3 to 0.8.
Eligibility Criteria
You may qualify if:
- Adult (\>18 years) patients
- Elective craniotomy
You may not qualify if:
- Repeat craniotomy
- Preoperative hypotension (defined as systolic blood pressure below 110 mmHg)
- Preoperative hypoxia (defined as peripheral oxygen saturation (SpO2) \< 90% without oxygen supplementation before surgery)
- No negative pregnancy test for women \<50 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rigshospitalet
Copenhagen, 2100, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Primary Investigator
Study Record Dates
First Submitted
August 28, 2018
First Posted
September 24, 2018
Study Start
September 24, 2018
Primary Completion
October 1, 2020
Study Completion
October 1, 2020
Last Updated
November 3, 2020
Record last verified: 2020-11